Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • MAINTAIN Trial: Shaping Post-CDK4/6i Strategies in HR+/HER2− Metastatic Breast Cancer

    Although published in 2023, the MAINTAIN trial remains a key reference in the evolving management of HR+/HER2− metastatic breast cancer following progression on CDK4/6 inhibitors.In this randomized, placebo-controlled phase II…

    2025.07.07
  • ESMO China Voice | Dr. Cheng Huang & Dr. Rongbo Lin: Global First Evidence Shows IV IPCA Outperforms Oral Morphine for Severe Cancer Pain, Potentially Changing Guidelines and Transforming Pain Management

    The 2024 European Society for Medical Oncology (ESMO) Annual Meeting was held in Barcelona, Spain. A Phase III randomized controlled trial (SYLT-021), led by Dr. Rongbo Lin’s team from the Department of Gastrointestinal Oncology, Fujian Cancer Hospital, was selected as one of six Proffered Paper oral presentations in the palliative care session. This study compared…

    2025.07.07
  • Precision Immunotherapy for Gastric Cancer: Insights from the Latest Guideline Updates – By Zhi Peng

    2025.07.07
  • Addressing Hemorrhagic Cystitis in HCT: Insights from Dr. Simone Cesaro on BK Virus Surveillance and Clinical Practice Gaps

    In this exclusive interview with Infectious Diseases Frontier, Professor Simone Cesaro, a leading expert in pediatric hematology and stem cell transplantation, shares his perspectives on the management of BK polyomavirus-associated hemorrhagic cystitis (HC) following hematopoietic cell transplantation (HCT). Drawing from the findings of a recent EBMT survey, he discusses the clinical implications of passive surveillance…

    2025.07.04
  • EBMT 2025: Opening Ceremony Celebrates Legacy, Innovation, and a Unified Vision for the Future of Transplantation

    Florence, Italy — March 30, 2025 – The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) commenced in Florence with a compelling and multifaceted opening ceremony that captured the essence of what the EBMT represents. Far beyond a traditional welcome, the evening unfolded as a rich tapestry of scientific achievement,…

    2025.07.04
  • Celebrating Excellence at EBMT 2025: Award Highlights from Florence

    Best Essay Awards: Thought Leadership Through the “Five Best Essays” In a session both engaging and reflective, five finalists presented their original essays tackling some of the most pressing and…

    2025.07.04
  • EBMT 2025 Closing Ceremony: A Celebration of Progress and Community

    Springer Nature Poster Awards: Honoring Scientific Excellence at EBMT 2025 The first segment of the EBMT 2025 Closing Ceremony, led by Dr. Anna Sureda, paid tribute to the remarkable scientific…

    2025.07.04
  • Parallel SessionEvolution of lmmunother

    2025.07.03
«previous next»
Recent Posts
  • Advancing Precision Therapy in Urothelial Carcinoma: A Collaborative Study by Professors Xuesong Li, Qi Tang, Jianhua Zhang, and Xiaoying Li Explores a Novel Approach to HER2 Assessment
  • Disitamab Vedotin–Based Combination Strategy Redefines First-Line Treatment for Advanced Urothelial Carcinoma, Nearly Doubling Overall Survival
  • 2025 Tianjin International Breast Cancer Conference | Prof. Jihui Hao: A Blueprint for Intelligent Breast Cancer Prevention and Care
  • 2025 Tianjin International Breast Cancer Conference | Prof. Zhongsheng Tong: Targeted Therapy Frontiers and the “Tianjin Experience”
  • 2025 Yat-sen Breast Cancer Conference | Prof. Qiang Liu: Advancing Multidisciplinary Care for Breast Cancer in China
Recent Comments
    Archives
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top